Novo Nordisk announces major expansion of Chartres manufacturing site in France
Novo Nordisk, a global healthcare leader, has announced a significant investment exceeding 16 billion Danish kroner (2.1 billion euros), slated to begin in 2023, to ... Read More
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a deal that further strengthens its portfolio in ... Read More
Novo Nordisk to acquire Canadian pharma company Inversago Pharma
Danish pharma major Novo Nordisk A/S has confirmed its plan to acquire Montreal-based Inversago Pharma. The potential cash deal, reaching up to $1.075 billion, hinges ... Read More
Novo Nordisk commits $2.3bn for expansion of Danish API production plant
Novo Nordisk, a Danish pharmaceutical firm, has declared its intention to funnel DKK 15.9 billion ($2.3 billion) into expanding an existing Active Pharmaceutical Ingredient (API) ... Read More
Rigel Pharmaceuticals gets Rezlidhia FDA approval for AML
Rigel Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Rezlidhia (olutasidenib) capsules for relapsed or refractory (R/R) acute myeloid ... Read More
Novo Nordisk acquires SCD drug developer Forma Therapeutics
Novo Nordisk acquisition of Forma Therapeutics : Danish pharma company Novo Nordisk has closed the previously announced $1.1 billion acquisition of Forma Therapeutics, a clinical-stage ... Read More
HCL Technologies to help Novo Nordisk in IT transformation
HCL Technologies said that it has been roped in by Danish pharma company Novo Nordisk for providing global service desk and on-site support to the ... Read More
Novo Nordisk signs $3.3bn deal to acquire Dicerna Pharmaceuticals
Novo Nordisk has signed a deal worth around $3.3 billion to acquire Dicerna Pharmaceuticals, a US-based biotech company focused on developing ribonucleic acid interference (RNAi) ... Read More
Novo Nordisk secures FDA approval for Saxenda label update targeting adolescent obesity treatment
Novo Nordisk, a global leader in diabetes and obesity care, has received approval from the US Food and Drug Administration (FDA) for an updated label ... Read More
Novo Nordisk to acquire US drug delivery company Emisphere Technologies
Danish pharma company Novo Nordisk has agreed to acquire US drug delivery company Emisphere Technologies in a deal worth $1.8 billion. The proprietary drug delivery ... Read More